Skip to main content
. Author manuscript; available in PMC: 2017 Mar 8.
Published in final edited form as: Epidemiology. 2016 May;27(3):438–448. doi: 10.1097/EDE.0000000000000456

Table 3.

Participation a in baseline and first two follow-up visits, LEGACY Girls Study, 2011–2015

Baselinevisit Follow-up 1(at 6 months) Follow-up 2 (at 12 months)
N (%) N (%) N (%)

Visit completed 1,040 b 1,003 (96%) c 977 (94%) c
 Withdrawal from study 12 12
 Not available or declined visit 25 39
Questionnaires completed by mothers/guardians
 Growth and Development Questionnaire 999 (96%) 953 (92%) 900 (87%)
 Behavioral Questionnaire 945 (91%) d n/a 916 (88%) e
Questionnaires completed by daughters
 Daughters ages ≥10 years 530 604 686
 Growth and Development Questionnaire 510 (96%) 546 (90%) 602 (88%)
 Behavioral Questionnaire 481 (91%) n/a 610 (89%)
Biospecimen collection
 Urine 1,014 (98%) 951 (91%) 915 (88%)
 Blood 427 (41%) 404 (39%) n/a
 Saliva 587 (56%) 340 f 454 f
Anthropometry completed 1,020 (98%) 954 (92%) 923 (89%)
Clinical breast Tanner staging g
 Daughters offered Tanner staging 305 292 285
 Tanner staging completed 254 (83%) 247 (85%) 234 (82%)
a

Participation rates are provided for the baseline cohort of 1,040 girls, unless specified otherwise.

b

Number of girls enrolled in cohort.

c

Completion of at least one component of follow-up visit.

d

At baseline, the Behavioral Questionnaire was not offered to mothers/guardians of 67 girls who spoke Spanish only or due to delayed IRB approval.

e

At the second follow-up, the Behavioral Questionnaire was not offered to mothers/guardians of 27 girls who spoke Spanish only.

f

Includes repeat saliva samples for some girls.

g

Clinical breast Tanner staging was performed at the New York and Utah study sites only.